Welcome to Markets Desk, here's what's moving the needle today.
Arista Networks continues to draw serious attention as the backbone of AI infrastructure buildout, with its high-bandwidth networking gear sitting at the center of data center demand. As we look toward two thousand twenty-six, the question isn't whether AI spending continues — it's who captures the most durable margin from it, and Arista's positioning remains difficult to argue with.
Shifting macro, the Financial Times is raising a comparison that should unsettle anyone watching Beijing closely — the parallel between China's property-driven slowdown and Japan's lost decades. A debt-heavy real estate collapse that bleeds into broader economic stagnation is precisely the scenario Xi Jinping's growth targets cannot survive, and the structural similarities are becoming harder to dismiss.
Meanwhile in biotech capital markets, Alpha Teknova priced a public offering of eight million common shares at five dollars each, raising forty million dollars in gross proceeds. For a life sciences reagent supplier, this raise signals a need for runway — investors will be watching closely how that capital gets deployed against the company's near-term commercial commitments.
That's the tape. Markets Desk, signing off the floor.
